These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 9443575
1. C-erbB-2 amplification and expression in gestational trophoblastic disease correlates with DNA content and karyotype. Bauer M, Horn LC, Kowalzik J, Mair W, Czerwenka K. Gen Diagn Pathol; 1997 Nov; 143(2-3):185-90. PubMed ID: 9443575 [Abstract] [Full Text] [Related]
2. Clinicopathologic profile of gestational trophoblastic disease. Jelincic D, Hudelist G, Singer CF, Bauer M, Horn LC, Bilek K, Czerwenka K. Wien Klin Wochenschr; 2003 Jan 31; 115(1-2):29-35. PubMed ID: 12658908 [Abstract] [Full Text] [Related]
3. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy. Niemann I, Hansen ES, Sunde L. Gynecol Oncol; 2007 Feb 31; 104(2):411-5. PubMed ID: 17011616 [Abstract] [Full Text] [Related]
4. Expression of maspin in gestational trophoblastic disease. Li HW, Leung SW, Cheung AN, Yu MM, Chan LK, Wong YF. Gynecol Oncol; 2006 Apr 31; 101(1):76-81. PubMed ID: 16271752 [Abstract] [Full Text] [Related]
5. Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor. Lage JM, Berkowitz RS, Rice LW, Goldstein DP, Bernstein MR, Weinberg DS. Obstet Gynecol; 1991 Jan 31; 77(1):111-5. PubMed ID: 1845777 [Abstract] [Full Text] [Related]
6. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor. Tuncer ZS, Vegh GL, Fulop V, Genest DR, Mok SC, Berkowitz RS. Gynecol Oncol; 2000 Jun 31; 77(3):389-93. PubMed ID: 10831347 [Abstract] [Full Text] [Related]
7. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease. Persaud V, Ganjei P, Nadji M. West Indian Med J; 1993 Dec 31; 42(4):142-3. PubMed ID: 7909185 [Abstract] [Full Text] [Related]
9. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole. Yang X, Zhang Z, Jia C, Li J, Yin L, Jiang S. Gynecol Oncol; 2002 Jun 31; 85(3):438-44. PubMed ID: 12051871 [Abstract] [Full Text] [Related]
10. Genetic aspects of gestational trophoblastic diseases: a general overview with emphasis on new approaches in determining genetic composition. Lage JM, Sheikh SS. Gen Diagn Pathol; 1997 Nov 31; 143(2-3):109-15. PubMed ID: 9443568 [Abstract] [Full Text] [Related]
13. [Association of the novel hydatidiform mole-related gene F10 with the invasiveness of trophoblastic tumor]. Zhou J, Chen SL, Xing FQ, Pang ZJ, Li B, Zhou WQ, Fu X, Ding YQ. Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb 31; 25(2):171-3. PubMed ID: 15698997 [Abstract] [Full Text] [Related]
14. Complete hydatidiform mole with retained maternal chromosomes 6 and 11. McConnell TG, Norris-Kirby A, Hagenkord JM, Ronnett BM, Murphy KM. Am J Surg Pathol; 2009 Sep 31; 33(9):1409-15. PubMed ID: 19542869 [Abstract] [Full Text] [Related]
15. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy. Sebire NJ, Rees HC, Peston D, Seckl MJ, Newlands ES, Fisher RA. Histopathology; 2004 Aug 31; 45(2):135-41. PubMed ID: 15279631 [Abstract] [Full Text] [Related]
16. [Genetic studies of hydatidiform mole with 46,XY karyotype (author's transl)]. Ohama K, Okamoto E, Nomura K, Fujiwara A, Fukuda Y. Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct 31; 33(10):1664-8. PubMed ID: 6458639 [Abstract] [Full Text] [Related]
19. Flow cytometric analysis of nuclear DNA content in gestational trophoblastic disease. Lage JM. J Reprod Med; 1991 Jan 31; 36(1):31-5. PubMed ID: 1848897 [Abstract] [Full Text] [Related]